EACR-Boehringer Ingelheim Drugging and Regulating the MAP Kinase Pathway

Conference details

Join the second edition of this topic to focus on the basic and clinical aspects of the regulation of the MAPK pathway and gain new insights about the mechanisms of action of the new generation of pan-RAS inhibitors and rational combination therapies

New conferences posted daily. Subscribe for real-time updates.

We care about your data. Read our privacy policy .

Similar Conferences

About the conference

Conference on

Country

Other

Categories

Published on

19 November 2024

Total Views

89

Organizers

  • The European Association for Cancer Research and Boehringer Ingelheim

    The European Association for Cancer Research and Boehringer Ingelheim

    Title
    Role